GSK plc (GSK,GSK.L), and Shionogi & Co. announced the completion of the transaction for the 11.7% economic interest in ViiV Healthcare previously held by Pfizer (PFE) to be replaced with an investment by Shionogi (4507.T). Shionogi has increased its economic interest in ViiV Healthcare to 21.7%. GSK maintains 78.3% majority owned economic interest.
ViiV issued new shares to Shionogi for $2.125 billion and cancelled Pfizer's holding in ViiV Healthcare. Pfizer received $1.875 billion. GSK received a special dividend of $0.250 billion.
At last close, GSK shares were trading at 2,064.00 pence, up 0.05%.
For More Such Health News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.